Treatment with lumasiran improved kidney outcomes in patients with primary hyperoxaluria type 1, with no cases of end-stage kidney disease observed during follow-up in a study presented at Kidney Week....
In a study presented at the 103rd American Association of Plastic Surgeons Annual Meeting, researchers assessed whether liposomal bupivacaine improves pain control, opioid use, or length of stay after...
In a study presented at the 103rd American Association of Plastic Surgeons Annual Meeting, researchers assessed whether liposomal bupivacaine improves pain control, opioid use, or length of stay after...
In a study presented at the 103rd American Association of Plastic Surgeons Annual Meeting, researchers assessed whether liposomal bupivacaine improves pain control, opioid use, or length of stay after...
A multicenter cross-sectional study presented at the American Heart Association Scientific Sessions 2025 found that one in three patients with hypertrophic cardiomyopathy experience heart failure, with...
A multicenter cross-sectional study presented at the American Heart Association Scientific Sessions 2025 found that one in three patients with hypertrophic cardiomyopathy experience heart failure, with...
A multicenter cross-sectional study presented at the American Heart Association Scientific Sessions 2025 found that one in three patients with hypertrophic cardiomyopathy experience heart failure, with...
A multicenter cross-sectional study presented at the American Heart Association Scientific Sessions 2025 found that one in three patients with hypertrophic cardiomyopathy experience heart failure, with...
In a qualitative study of physicians managing patients with primary hyperoxaluria type 1 (PH1), presented at Kidney Week 2025, clinicians emphasized simplicity, patient convenience, and ease of...
In a qualitative study of physicians managing patients with primary hyperoxaluria type 1 (PH1), presented at Kidney Week 2025, clinicians emphasized simplicity, patient convenience, and ease of...
